Literature DB >> 19616462

Natural history of Niemann-Pick disease type C in a multicentre observational retrospective cohort study.

J E Wraith1, N Guffon, M Rohrbach, W L Hwu, G C Korenke, B Bembi, C Luzy, R Giorgino, F Sedel.   

Abstract

Niemann-Pick disease type C (NP-C) is a devastating genetic disorder characterised by progressive neurological deterioration. However, data on the progression of neurological manifestations, particularly across different patient age-of-disease onsets, are limited. This is an observational retrospective cohort study designed to assess the progression of neurological disease in patients with NP-C. Physicians were asked to retrospectively complete a web-based questionnaire for each patient, at diagnosis and at up to three follow-up visits. An NP-C-specific disability scale was used to measure disease progression. The scale comprised four key parameters of neurological disease progression; ambulation, manipulation, language and swallowing. Disease progression was evaluated based on the annual rate of change in each parameter and the composite score using a linear mixed model analysis, and by classifying patients according to the number of worsened parameters during the observation period. Data were collected from 57 patients. The rate of deterioration was similar across the four individual parameters of the disability scale. The mean (95% CI) annual disease progression was +0.12 (0.09, 0.15) units. Among patients with a time interval of at least 1 year between diagnosis and last visit (n=49), 42 (86%) patients had progressed disease and 7 (14%) patients had stable disease. Disease progression was consistently more rapid in patients diagnosed in early childhood, compared with those diagnosed in late childhood, or with juvenile or adult presentation. In conclusion, our findings showed a progression in all four parameters of the disability scale, representing a continuous, unbroken progression of neurological manifestations.

Entities:  

Mesh:

Year:  2009        PMID: 19616462     DOI: 10.1016/j.ymgme.2009.06.009

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  39 in total

Review 1.  Niemann-pick disease type C: implications for sedation and anesthesia for diagnostic procedures.

Authors:  Ning Miao; Xiaowei Lu; Naomi P O'Grady; Nicole Yanjanin; Forbes D Porter; Zenaide M N Quezado
Journal:  J Child Neurol       Date:  2012-02-28       Impact factor: 1.987

2.  Niemann-Pick disease type C in the newborn period: a single-center experience.

Authors:  Ersin Gumus; Goknur Haliloglu; Asuman Nur Karhan; Hulya Demir; Figen Gurakan; Meral Topcu; Aysel Yuce
Journal:  Eur J Pediatr       Date:  2017-09-27       Impact factor: 3.183

Review 3.  Lysosomal storage disease overview.

Authors:  Angela Sun
Journal:  Ann Transl Med       Date:  2018-12

4.  Long-term efficacy of miglustat in paediatric patients with Niemann-Pick disease type C.

Authors:  Y H Chien; S F Peng; C C Yang; N C Lee; L K Tsai; A C Huang; S C Su; C C Tseng; W L Hwu
Journal:  J Inherit Metab Dis       Date:  2012-04-05       Impact factor: 4.982

Review 5.  Miglustat: a review of its use in Niemann-Pick disease type C.

Authors:  Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2014-01       Impact factor: 9.546

6.  Altered vitamin E status in Niemann-Pick type C disease.

Authors:  L Ulatowski; R Parker; C Davidson; N Yanjanin; T J Kelley; D Corey; J Atkinson; F Porter; H Arai; S U Walkley; D Manor
Journal:  J Lipid Res       Date:  2011-05-05       Impact factor: 5.922

Review 7.  Niemann-Pick disease type C.

Authors:  Marie T Vanier
Journal:  Orphanet J Rare Dis       Date:  2010-06-03       Impact factor: 4.123

Review 8.  Niemann-Pick disease treatment: a systematic review of clinical trials.

Authors:  Alejandro Santos-Lozano; Diana Villamandos García; Fabian Sanchis-Gomar; Carmen Fiuza-Luces; Helios Pareja-Galeano; Nuria Garatachea; Gisela Nogales Gadea; Alejandro Lucia
Journal:  Ann Transl Med       Date:  2015-12

9.  Aberrant activation of Cdc2/cyclin B1 is involved in initiation of cytoskeletal pathology in murine Niemann-Pick disease type C.

Authors:  Li Ba; Zhi-Jun Li; Bi-Tao Bu; Wei Wang; Min Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20

10.  New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat.

Authors:  James E Wraith; Jackie Imrie
Journal:  Ther Clin Risk Manag       Date:  2009-11-18       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.